About DPB Antibiotics Private Limited
Data last updated:
DPB Antibiotics Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51397CH2010PTC046352. Its GSTIN is 27AADCD4334J1ZO (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹10 Lakh. It is led by directors including Devang Manharlal Ajmera and Piyush Manharlal Ajmera.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 73 Industrial Area, Phase 2, Chandigarh, India – 160002.
As per the financials filed for FY 2024, the company reported a revenue of ₹10,000, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹3.91 Lakh and EBITDA of -₹6.26 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 59% over five years.
The company is associated with 2 brands: Vardhman Chemtech and DPB Group. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 3 cases are pending. The company has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹1.18 Cr; the latest was in June 2021. Its 7 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 2 smaller; the largest is Active Medical Technologies Private Limited with revenue of ₹10,482.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dpbpharma.com.
Company details
CIN history
DPB Antibiotics has one previous CIN (Corporate Identification Number): U51397MH2010PTC201353. The current CIN is U51397CH2010PTC046352, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51397CH2010PTC046352 | Current |
| U51397MH2010PTC201353 | Previous |
Contact details
DPB Antibiotics Private Limited's registered office is in Chandigarh, Chandigarh.
- Registered AddressPlot No 73 Industrial Area, Phase 2, Chandigarh, India – 160002
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
DPB Antibiotics operates two associated brands: Vardhman Chemtech and DPB Group. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of bulk drugs, intermediates and fine chemicals | vardhmanchemtech.com | |
| DPB Group is engaged in manufacturing pharmaceutical APIs in India. | dpbpharma.com |
Financials of DPB Antibiotics Private Limited
FY 2024 filings availableDPB Antibiotics Private Limited reported revenue of ₹10,000 (down 100% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 59% over five years. EBITDA fell 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.91 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of DPB Antibiotics Private Limited, buy the company report.
Board of directors of DPB Antibiotics Private Limited
DPB Antibiotics has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devang Manharlal Ajmera | Director | 27 Mar 2010 | 16 Years 7 Months | Current |
| Piyush Manharlal Ajmera Also directs: Vardhman Chemtech Limited, DPB Pharmaceuticals Limited | Director | 27 Mar 2010 | 16 Years 7 Months | Current |
| Bhavin Manharlal Ajmera Also directs: Vardhman Chemtech Limited, DPB Pharmaceuticals Limited | Director | 27 Mar 2010 | 16 Years 7 Months | Current |
| Sharvan Bhatt | Additional Director | 03 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
DPB Antibiotics Private Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Active Medical Technologies Private Limited | ₹10,482 (FY 2025) | 11.0% | Mumbai, Maharashtra, India | |||
| Healthcare Pharma Trading Private Limited | ₹10,350 (FY 2023) | Shimla, Himachal Pradesh, India | ||||
| Ky Kabir Industries Private Limited | ₹10,200 (FY 2025) | -100.0% | Gurgaon, Haryana, India | |||
| Hope Remedies Private Limited | ₹10,061 (FY 2024) | 7.0% | Roorkee, Uttarakhand, India | |||
| DPB Antibiotics Private Limitedthis company | ₹10,000 (FY 2024) | -₹3.91 Lakh | -100.0% | Chandigarh, India | ||
| Hazun Un Package Praivate Limited | ₹10,000 (FY 2025) | -8.0% | Mumbai, Maharashtra, India | |||
| Newgen Labs (OPC) Private Limited | ₹10,000 (FY 2025) | Mangalgiri, Andhra Pradesh, India | ||||
| Sia Lifecare Private Limited | ₹9,880 (FY 2024) | -43.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of DPB Antibiotics Private Limited, buy the company report.
Deals & funding
DPB Antibiotics Private Limited has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹1.18 Cr; the latest was in June 2021.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: DPB Pharmaceuticals Limited & Devang Manharlal Ajmera, DPB Pharmaceuticals Limited & Piyush Manharlal Ajmera, DPB Pharmaceuticals Limited Seller: 3 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 3 individuals |
| Aug 2020 | Funding round | ₹1.18 Cr | Investors: Prosperity Pharmatech Private Limited , 3 individuals |
| Oct 2019 | Rights issue | ₹91.6 Lakh | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
DPB Antibiotics Private Limited has 6 court cases on record: 2 filed by DPB Antibiotics, 4 filed against it. 3 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 2 | 2 |
| NCLAT | 2 | 2 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed by the company against Lasa Supergenerics Limited and Ors | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Lasa Supergenerics Limited | Disposed |
| High Court, MAHARASHTRA | Arbitration matter | Filed against the company by Shreegen Pharma Limited | Disposed |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by individuals | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed by the company against PR Pharma Source Pvt Ltd and Ors. | Pending |
To see the full case history of DPB Antibiotics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
DPB Antibiotics Private Limited was last rated by Crisil on 11 Feb 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 11 Feb 2020 |
To see the full credit ratings and regulatory alerts of DPB Antibiotics Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for DPB Antibiotics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
DPB Antibiotics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCD4334J1ZO | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of DPB Antibiotics Private Limited, buy the company report.
Recent activity
DPB Antibiotics Private Limited has 5 board changes on record since 2010: 4 appointments and 1 cessation. The latest: Sharvan Bhatt was appointed as Additional Director on 03 Nov 2025.
Frequently asked questions
DPB Antibiotics is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 March 2010 (16+ years old) and is registered under CIN U51397CH2010PTC046352.
DPB Antibiotics has 4 current directors:
- Devang Manharlal Ajmera - Director
- Piyush Manharlal Ajmera - Director
- Bhavin Manharlal Ajmera - Director
- Sharvan Bhatt - Additional Director
The latest financial statements of DPB Antibiotics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of DPB Antibiotics is 27AADCD4334J1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of DPB Antibiotics is U51397CH2010PTC046352. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DPB Antibiotics has 6 court cases on record: 2 filed by the company and 4 filed against it. 3 are pending. Most are in the high courts.
DPB Antibiotics was incorporated on 27 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Chandigarh.
DPB Antibiotics has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹1.18 Cr; the latest was in June 2021.
The peers of DPB Antibiotics by revenue are Active Medical Technologies Private Limited, Healthcare Pharma Trading Private Limited, Ky Kabir Industries Private Limited, Hope Remedies Private Limited, Hazun Un Package Praivate Limited and 2 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sharvan Bhatt was appointed as Additional Director on 03 Nov 2025. Sharvan Bhatt ceased to be Additional Director on 30 Dec 2020. Bhavin Manharlal Ajmera was appointed as Director on 27 Mar 2010. DPB Antibiotics has 5 board changes on record in total.
DPB Antibiotics can be reached through the website dpbpharma.com. Its registered office is in Chandigarh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
